Aspirin Use After Diagnosis Improves Survival in Older Adults with Colon Cancer: A Retrospective Cohort Study
Objectives To assess survival in relation to aspirin use after diagnosis in older adults with colon cancer. Design Subgroup analysis of a previously published cohort and retrospective study. Setting Individuals registered in the Eindhoven Cancer Registry (ECR) between 1998 and 2007, linked to prescr...
Saved in:
Published in | Journal of the American Geriatrics Society (JAGS) Vol. 60; no. 12; pp. 2232 - 2236 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Hoboken, NJ
Blackwell Publishing Ltd
01.12.2012
Wiley-Blackwell Wiley Subscription Services, Inc |
Subjects | |
Online Access | Get full text |
ISSN | 0002-8614 1532-5415 1532-5415 |
DOI | 10.1111/jgs.12033 |
Cover
Summary: | Objectives
To assess survival in relation to aspirin use after diagnosis in older adults with colon cancer.
Design
Subgroup analysis of a previously published cohort and retrospective study.
Setting
Individuals registered in the Eindhoven Cancer Registry (ECR) between 1998 and 2007, linked to prescriptions of low‐dose aspirin (80 mg) registered in a community pharmacy database.
Participants
Five hundred thirty‐six individuals aged 70 and older diagnosed with colon cancer with or without aspirin use after diagnosis.
Measurements
Survival was analyzed with user status as a time‐dependent covariate. Multivariate Poisson regression survival models were used to study the effect of aspirin on overall survival.
Results
One hundred seven participants (20.0%) started aspirin after being diagnosed with colon cancer; 429 (80.0%) were not prescribed aspirin. Three hundred thirty‐nine participants (63.2%) had died by the end of follow‐up. Aspirin use after diagnosis was associated with longer overall survival (rate ratio (RR) = 0.51, 95% confidence interval (CI) = 0.38–0.70, P < .001). Multivariate proportional hazards regression analysis revealed that aspirin use was associated with longer overall survival (adjusted RR = 0.59, 95% CI = 0.44–0.81, P = .001).
Conclusion
Aspirin use after the diagnosis of colon cancer in older adults was associated with longer survival. Low‐dose aspirin could be used as an effective adjuvant therapy in older adults with colon cancer. |
---|---|
Bibliography: | ArticleID:JGS12033 ark:/67375/WNG-B79GQFFS-N istex:16BB57E83326C570A25AAFEB7AA92EDA4E620151 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 14 ObjectType-Article-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0002-8614 1532-5415 1532-5415 |
DOI: | 10.1111/jgs.12033 |